For more information on kratom and its effects, please consult the following resources: National Center for Complementary and Integrative Health (NCCIH) - Kratom Mayo Clinic - Kratom: Unsafe and ineffective National Institute on Drug Abuse (NIDA) - Kratom DrugFacts
[99] A person with cobalamin C disease, a rare autosomal, recessive, inheritance disease which results in combined methylmalonic aciduria and homocystinuria), [100] can be treated with intravenous or intramuscular hydroxocobalamin
Oral administration in GI-specific research For GI-focused protocols gastric ulcer, colitis, IBD, NSAID-induced enteropathy, hepatic protection oral administration is the logical primary route given: Direct delivery to the affected tissue Alignment with the peptides biological origin (gastric-juice fragment) Established preclinical precedent In these indications, oral dosing is often the primary route rather than a convenience alternative
The complementary mechanisms are believed to provide synergistic healing benefits